Does Dr. KARL SAARDI have financial conflicts of interest?

Dr. KARL SAARDI (M.D.) has received a total of $100,725 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $100,725 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. KARL SAARDI?

According to CMS Open Payments data, Dr. KARL SAARDI received funding from BOEHRINGER INGELHEIM PHARMACEUTICALS ($66,489), UCB ($13,918), and GALDERMA LABORATORIES, L.P ($8,028).

Does Dr. KARL SAARDI receive research grants or speaking fees?

Dr. KARL SAARDI has received $100,725 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. KARL SAARDI

M.D.Real-Time Hydrated

Specialty: Dermatology

Practice Location: WASHINGTON, DC 20037

NPI Number: 1114312410

LIFETIME INDUSTRY VALUE

$100,725

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. SAARDI is a verified Dermatology practitioner based in WASHINGTON, DC.

Between 2021 and 2025, Dr. SAARDI had an overall industry promotional and research financial footprint of $100,725 as recorded in the federal CMS Open Payments database.

$100,725 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. SAARDI's primary funding source is BOEHRINGER INGELHEIM PHARMACEUTICALS, which accounts for $66,489 (representing 66% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BOEHRINGER INGELHEIM PHARMACEUTICALS

Rank 1

$66,489

66%

UCB

Rank 2

$13,918

13.8%

GALDERMA LABORATORIES, L.P

Rank 3

$8,028

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.